AbstractBySubCategory

Prevention, Diagnosis, and Screening

Cancers of the Esophagus and Stomach

2017 Gastrointestinal Cancers Symposium

ABSTRACT TITLE FIRST AUTHOR ABSTRACT NO.sort descending
Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: Prospective randomized controlled trial. Yoon Ju Jung

07

Comprehensive genomic profiling (CGP) of esophageal and tubular GI tumors to identify frequencies of ErbB family member amplification with therapeutic implications. Mark Bailey

08

Effectiveness and limitations of staging laparoscopy for peritoneal metastases in advanced gastric cancer from the results of JCOG0501: A randomized trial of gastrectomy with or without neoadjuvant chemotherapy for type 4 or large type 3 gastric cancer. Shinji Hato

09

Patients of Asian descent with gastric cancer treated in the United States: Comparative characteristics and survival outcomes. Ryan Rhome

10

Germline ATM mutations in families with early-onset and familial gastroesophageal and colorectal cancers. Michael J. Hall

11

Central validation of HER2 status to determine heterogeneity of marker expression in HER2-positive gastric cancer (GC). Ivonne Haffner

12

Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in oesphageal squamous cell carcinoma. Yu-Bo Jiang

13

Underweight as a risk factor for esophageal squamous cellcarcinoma: A nationwide population-based study. Yoon Jin Choi

14

HER2 testing in gastric cancer diagnosis: Insights on variables influencing HER2-positivity from a large, multicenter, observational study in Germany. Gustavo Bruno Baretton

15

Association of UGT1A1 gene polymorphism with the safety and efficacy of irinotecan monotherapy for advanced gastric cancer. Toshifumi Yamaguchi

16

Young age, disparities, and survival in gastric adenocarcinoma: Implications for screening strategies. Shrawan G Gaitonde

17

Laparoscopic D2 gastrectomy with complete mesogastrium excision (D2+CME) to reduce cancer leak from mesogastrium in patients with advanced gastric cancer. Daxing Xie

18

Complement component C9 as a new biomarker for esophageal adenocarcinoma. Virendra Joshi

19

A retrospective analysis of eye disorders induced by chemotherapy including S-1 for gastrointestinal cancer. Masataka Yagisawa

20

A proposal for a novel and simple TNM staging for gastric cancer. Taeil Son

21

Clinical significance of p53 protein, beta-catenin, and HER2 in patients with Epstein-Barr virus-associated gastric cancer. Dong Won Baek

22

Oesophageal cancer: Commonly familial, possibly heritable. Niamh Peters

23

Long-term quality of life comparison after endoscopic submucosal dissection versus surgery in early gastric cancer patients. Young-Il Kim

24

Racial and ethnic disparities among young patients with gastric cancer. Ibrahim Nassour

25

Laparoscopic function-preserving gastrectomy based on sentinel node concept for early gastric cancer patients. Hiroya Takeuchi

26

Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: Results of GASTric cancer HER2 reassessment study 3 (GASTHER3). Seyoung Seo

27

Effect of a mixed type Lauren's classification on agressiveness and lymph node metastasis in early gastric cancer. Jeunghui Pyo

28

Serum HER2 level during chemotherapy as a biomarker for advanced gastric cancer. Mayuko Saito

29

The efficacy of stratifying patients with laparoscopic gastrectomy at age, body mass index and preoperative serum C-reactive protein level for predicting an incidence ratio of postoperative complications. En Amada

31

Predictive factors of residual tumor for the patients with non-curative resection after endoscopic submucosal dissection for early gastric cancer. Hideki Sunagawa

32

Identification of circulating microRNAs for the diagnosis of early-stage gastric cancer. Anna Brunet-Vega

33

Role of nutritional and inflammatory status in the prognosis of advanced gastric cancer. Antía Cousillas

35

Prognostic significance of preoperative plasma fibrinogen and Albumin Score in esophageal cancer patients. Yusuke Maeda

36

Prognostic value of immunohistochemical factors in esophageal small cell carcinoma (ESCC): Analysis of clinicopathologic features of 73 patients. Cong Li

37

Tumor infiltrative pattern predicts sites of recurrence after curative gastrectomy for gastric cancer. Mitsuro Kanda

38

NM 23-H1 gene expression of a migration suppressor in gastric lymphoma. Il Kim

39

Long-term survival of gastrointestinal cancer diagnosed in Hodgkin lymphoma survivors. Lisanne Sara Rigter

40

Prognostic factors of trastuzumab-based chemotherapy in patients with advanced HER2 positive gastric cancer. Shoko Marshall

41

A new complementary approach to endoscopy for esophageal cancer diagnosis. Gengxi Jiang

42

Short-term outcomes of laparoscopic D2 gastrectomy with complete mesogastrium excision (D2+CME) for advanced gastric cancer. Daxing Xie

43

Incidence and prognostic significance of extramural venous invasion in T3-4 esophageal cancer. Zohra Faiz

44

Chemotherapy and survival benefit in elderly patients with advanced gastric cancer. Aya Sugimoto

45